Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neuphoria Therapeutics (NEUP) Pension (2022 - 2023)

Neuphoria Therapeutics (NEUP) has disclosed Pension for 2 consecutive years, with $14969.9 as the latest value for Q2 2023.

  • Quarterly Pension rose 99.81% to $14969.9 in Q2 2023 from the year-ago period, while the trailing twelve-month figure was $14969.9 through Jun 2023, up 99.81% year-over-year, with the annual reading at $15083.2 for FY2023, 101.32% up from the prior year.
  • Pension for Q2 2023 was $14969.9 at Neuphoria Therapeutics, up from $7492.2 in the prior quarter.
  • The five-year high for Pension was $14969.9 in Q2 2023, with the low at $7492.2 in Q2 2022.